Recent genomic-wide association studies conducted to determine the cause of these clinical differences have shown that some polymorphisms in ATP-binding cassette G2 (ABCG2) lead to hyperuricemia through renal overload and renal underexcretion and also increase the risk of early-onset gout. The gene discussed is ABCG2; the disease is hyperuricemia.